JOSE MANUEL
VALDIVIELSO REVILLA
CON
![Foto de JOSE MANUEL](/img/nophoto.png)
![Foto de Hospital Arnau de Vilanova](/img/noimage_org.png)
Hospital Arnau de Vilanova
Valencia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Arnau de Vilanova (32)
2024
-
Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort
Sleep Medicine, Vol. 116, pp. 19-26
-
Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum
Frontiers in Endocrinology, Vol. 15
2023
2021
-
Clinical usefulness of anthropometric indices to predict the presence of prediabetes. Data from the Ilervas cohort
Nutrients, Vol. 13, Núm. 3, pp. 1-15
2020
-
Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients
Nephrology Dialysis Transplantation, Vol. 35, Núm. 1, pp. 130-138
-
Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis
Nature Communications, Vol. 11, Núm. 1
2019
-
Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 34, Núm. 12, pp. 2079-2088
-
Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project
Cardiovascular Diabetology, Vol. 18, Núm. 1
-
Lung function measurements in the prediabetes stage: data from the ILERVAS Project
Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012
-
Sex hormones and their influence on chronic kidney disease
Current Opinion in Nephrology and Hypertension, Vol. 28, Núm. 1, pp. 1-9
-
Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project
Diabetes and Metabolism
2018
2017
-
Effects of the administration of 25(OH) vitamin D3 in an experimental model of chronic kidney disease in animals null for 1-alpha-hydroxylase
PLoS ONE, Vol. 12, Núm. 1
-
Low Serum Levels of Vitamin D are Associated with Progression of Subclinical Atherosclerotic Vascular Disease in Peritoneal Dialysis Patients: A Prospective, Multicenter Study
Nephron, Vol. 136, Núm. 2, pp. 111-120
-
Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease
Atherosclerosis, Vol. 260, pp. 130-137
-
The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease
PLoS ONE, Vol. 12, Núm. 11
2016
-
Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease
Atherosclerosis, Vol. 253, pp. 135-143
-
Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD
Clinical Journal of the American Society of Nephrology, Vol. 11, Núm. 2, pp. 287-296
-
Soluble TWEAK and major adverse cardiovascular events in patients with CKD
Clinical Journal of the American Society of Nephrology, Vol. 11, Núm. 3, pp. 413-422